Patent directory · USPTO A61K / A61P
Patents matching “inhibitors”
2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11034705
Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors
granted -
US 11026947
ALK2 inhibitors and methods for inhibiting BMP signaling
granted -
US 11028079
Small molecule BET bromodomain inhibitors and uses thereof
granted -
US 11026905
STAT3 inhibitors
granted -
US 11028083
Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases
granted -
US 11026931
Methods for the administration of certain VMAT2 inhibitors
granted -
US 11028120
CD73 inhibitors
granted -
US 2021163596
IMMUNOMODULATORY IL-2 AGENTS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS
granted -
US 11021465
DNA-PK inhibitors
granted -
US 11020391
CRMP2 sumoylation inhibitors and uses thereof
granted -
US 11021458
Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors
granted -
US 11021469
Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same
granted -
US 11021468
TGF-ß inhibitors
granted -
US 11013740
Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
granted -
US 11013743
Cancer treatments using combinations of CDK and ERK inhibitors
granted -
US 11013782
Methods of treating chronic disorders with complement inhibitors
granted -
US 11008304
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
granted -
US 11008305
DNA-PK inhibitors
granted -
US 11007184
Cancer treatments using combinations of type 2 MEK and ERK inhibitors
granted -
US 11008325
Inhibitors of cancer invasion, attachment, and/or metastasis
granted -
US 11007183
Cancer treatments using combinations of PI3K/Akt pathway and ERK inhibitors
granted -
US 11000513
Anhydrous compositions of mTOR inhibitors and methods of use
granted -
US 11001592
DNA polymerase IIIC inhibitors and use thereof
granted -
US 11001613
TFPI inhibitors and methods of use
granted